HCV Peptide (35-44)
Modify Date: 2025-08-20 14:30:53
HCV Peptide (35-44) structure
|
Common Name | HCV Peptide (35-44) | ||
|---|---|---|---|---|
| CAS Number | 160214-01-7 | Molecular Weight | 1240.50000 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C57H97N19O12 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of HCV Peptide (35-44)HCV Peptide (35-44), a HCV core protein at positions 35 to 44, is a HLA-A2-restricted CTL epitope. HCV Peptide (35-44) inhibits NK cell activity via two distinct mechanisms, directly via KIR2DL2/3, and synergistically via the CD94:NKG2A receptor[1]. |
| Name | Hepatitis C virus core protein(35-44) |
|---|---|
| Synonym | More Synonyms |
| Description | HCV Peptide (35-44), a HCV core protein at positions 35 to 44, is a HLA-A2-restricted CTL epitope. HCV Peptide (35-44) inhibits NK cell activity via two distinct mechanisms, directly via KIR2DL2/3, and synergistically via the CD94:NKG2A receptor[1]. |
|---|---|
| Related Catalog | |
| In Vitro | HCV Peptide (35-44) (0-100 μM) 抑制总 NK 细胞群的脱颗粒。 HCV 肽 (35-44) 增加 HLA-C 和 HLA-E 的细胞表面表达[1]。 |
| References |
| Molecular Formula | C57H97N19O12 |
|---|---|
| Molecular Weight | 1240.50000 |
| Exact Mass | 1239.76000 |
| PSA | 513.57000 |
| LogP | 4.16690 |
| C35-44 |
| peptide C 35-44 |
| YLLPRRGPRL |
| peptide C35-44 |